Cannabinoid Receptor Agonists
"Cannabinoid Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS.
| Descriptor ID |
D063386
|
| MeSH Number(s) |
D27.505.519.625.085.500 D27.505.696.399.472.188.500
|
| Concept/Terms |
Cannabinoid Receptor Agonists- Cannabinoid Receptor Agonists
- Agonists, Cannabinoid Receptor
- Receptor Agonists, Cannabinoid
- Cannabinoid Receptor Activators
- Activators, Cannabinoid Receptor
- Receptor Activators, Cannabinoid
- Cannabinoid Agonists
- Agonists, Cannabinoid
|
Below are MeSH descriptors whose meaning is more general than "Cannabinoid Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Cannabinoid Receptor Agonists".
This graph shows the total number of publications written about "Cannabinoid Receptor Agonists" by people in this website by year, and whether "Cannabinoid Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cannabinoid Receptor Agonists" by people in Profiles.
-
Distress tolerance and reactivity to negative affective cues in naturalistic environments of cannabis-using emerging adults. Drug Alcohol Depend. 2022 09 01; 238:109588.
-
Changes in striatal dopamine release, sleep, and behavior during spontaneous ?-9-tetrahydrocannabinol abstinence in male and female mice. Neuropsychopharmacology. 2022 07; 47(8):1537-1549.
-
Cannabinoid use is enhanced by stress and changes conditioned stress responses. Neuropsychopharmacology. 2022 04; 47(5):1037-1045.
-
Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli. Behav Brain Res. 2021 10 11; 415:113517.
-
Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects. Psychopharmacology (Berl). 2022 May; 239(5):1337-1347.
-
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis. 2021 Jun 22; 15(6):1032-1048.
-
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis. J Cyst Fibros. 2021 01; 20(1):78-85.
-
?9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Int J Mol Sci. 2020 Aug 28; 21(17).
-
The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors. Addict Biol. 2020 11; 25(6):e12843.
-
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism. Sci Rep. 2017 02 13; 7:42157.